Xiaofang Wang
No.270 Dong'an Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Prospective Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy for Patients With 1 to 10 Brain Metastases From Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 17, 2025
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2024
Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trial.
Journal: Scientific reports
Published: October 04, 2024
Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial.
Journal: Clinical and translational radiation oncology
Published: August 08, 2024
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field.
Journal: Breast cancer (Tokyo, Japan)
Published: August 07, 2024
Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Journal: Scientific reports
Published: April 16, 2024
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
Journal: BMC cancer
Published: September 16, 2023
MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner.
Journal: Cell death & disease
Published: September 15, 2023
Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Journal: Scientific reports
Published: August 24, 2023
Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions.
Journal: Radiation oncology (London, England)
Published: October 05, 2022
Last Updated: 09/26/2026